Literature DB >> 18036157

Is the modulation of retinoid and retinoid-associated signaling a future therapeutic strategy in neurological trauma and neurodegeneration?

Andrea Malaspina1, Adina T Michael-Titus.   

Abstract

The complex molecular pathways that mediate the effects of vitamin A and its derivatives, are increasingly recognized as a component of the repair capacity that could be activated to induce protection and regeneration in the mature nervous tissue. Retinoid and retinoid-associated signaling plays an essential role in normal neurodevelopment and appears to remain active in the adult CNS. In this paper, we review evidence which supports the hypothesis of an activation of retinoid-associated signaling molecular pathways in the mature nervous tissue and its significance in the context of neurodegenerative, trauma-induced and psychiatric disorders, at spinal and supra-spinal levels. Finally, we summarize the potential therapeutic avenues based on the modulation of retinoid targets undergoing reactivation under conditions of acute injury and chronic degeneration in the central nervous system, and discuss some of the unresolved issues linked to this treatment strategy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036157     DOI: 10.1111/j.1471-4159.2007.05071.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date.

Authors:  Vladimir Lerner; Peter J A McCaffery; Michael S Ritsner
Journal:  CNS Drugs       Date:  2016-04       Impact factor: 5.749

2.  A retinoic acid receptor agonist Am80 rescues neurons, attenuates inflammatory reactions, and improves behavioral recovery after intracerebral hemorrhage in mice.

Authors:  Hideaki Matsushita; Masanori Hijioka; Akinori Hisatsune; Yoichiro Isohama; Koichi Shudo; Hiroshi Katsuki
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-16       Impact factor: 6.200

3.  Cognitive Status and Nutritional Markers in a Sample of Institutionalized Elderly People.

Authors:  María Leirós; Elena Amenedo; Marina Rodríguez; Paula Pazo-Álvarez; Luis Franco; Rosaura Leis; Miguel-Ángel Martínez-Olmos; Constantino Arce
Journal:  Front Aging Neurosci       Date:  2022-05-24       Impact factor: 5.702

Review 4.  Significance of vitamin A to brain function, behavior and learning.

Authors:  Christopher R Olson; Claudio V Mello
Journal:  Mol Nutr Food Res       Date:  2010-04       Impact factor: 5.914

5.  All-trans-retinoic acid reduces BACE1 expression under inflammatory conditions via modulation of nuclear factor κB (NFκB) signaling.

Authors:  Ruishan Wang; Shaoya Chen; Yingchun Liu; Shiyong Diao; Yueqiang Xue; Xiaoqing You; Edwards A Park; Francesca-Fang Liao
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

6.  The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression.

Authors:  Natasa Jokic; Ping K Yip; Adina Michael-Titus; John V Priestley; Andrea Malaspina
Journal:  BMC Genomics       Date:  2010-11-15       Impact factor: 3.969

7.  Supplementation of adult rats with moderate amounts of β-carotene modulates the redox status in plasma without exerting pro-oxidant effects in the brain: a safer alternative to food fortification with vitamin A?

Authors:  Carlos Eduardo Schnorr; Maurilio da Silva Morrone; André Simões-Pires; Leonardo da Silva Bittencourt; Fares Zeidán-Chuliá; José Cláudio Fonseca Moreira
Journal:  Nutrients       Date:  2014-12-01       Impact factor: 5.717

8.  Retinoic acid protects from experimental cerebral infarction by upregulating GAP-43 expression.

Authors:  Y Li; X Gao; Q Wang; Y Yang; H Liu; B Zhang; L Li
Journal:  Braz J Med Biol Res       Date:  2017-04-03       Impact factor: 2.590

9.  Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS.

Authors:  Michael S Bereman; Joshua Beri; Jeffrey R Enders; Tara Nash
Journal:  Sci Rep       Date:  2018-11-05       Impact factor: 4.379

Review 10.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.